2021
DOI: 10.1002/bco2.61
|View full text |Cite
|
Sign up to set email alerts
|

Bladder cancer biomarkers: Past and future directions

Abstract: Overall, the results of Vasdev's et al's study are quite impressive with promising results. One must be cautious in applying this preliminary data to clinical practice for reasons stated above. Despite these concerns, this study along with others demonstrate the advances in inquiries within the field of bladder cancer with the potential to shape management and outcomes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 5 publications
0
1
0
Order By: Relevance
“…Janet Kukreja from our editorial board helped review and optimize this paper, and expands her thoughts on this biomarker in the broader context with an editorial comment. 2 We look forward to further validation studies. To the Journals… We have one review this issue 3 ; a collaboration between United Kingdom and Australian authors on a systematic review/meta‐analysis of ductal adenocarcinoma of the prostate.…”
mentioning
confidence: 99%
“…Janet Kukreja from our editorial board helped review and optimize this paper, and expands her thoughts on this biomarker in the broader context with an editorial comment. 2 We look forward to further validation studies. To the Journals… We have one review this issue 3 ; a collaboration between United Kingdom and Australian authors on a systematic review/meta‐analysis of ductal adenocarcinoma of the prostate.…”
mentioning
confidence: 99%